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Mutants of type 5 adenovirus (Ad5) with reiterated DNA sequences in the E1a region appeared in a human T-lymphocyte
cell line, Molt-4, persistently infected with H5sub304, a deletion/substitution mutant that has a wild-type phenotype in viral
replication. Endonuclease analyses and DNA sequencing revealed DNA reiteration in each mutant. In the four representative
mutants investigated, the DNA reiterations all started within a six-base-pair consensus sequence, G(or C)CTGTG, located
in the second exon of the E1a region (at nt 1333, 1367, or 1419). There was not any DNA homology between the breakpoints
in the second exon and the inserting sequences (starting at nt 532, 710, or 792). Northern analyses suggested that the
reiterated splicing sites of the representative mutants were all used in RNA splicing, and the closest donor and recipient
joints were used most frequently. These observations imply that during persistent infection Ad5 underwent spontaneous
mutations by sequence-specific breakage and nonhomologous end–end joining recombination events. These E1a reiteration
mutants could be propagated in HeLa, A549, and KB cells; they were genetically stable; and they killed CREF cells at a
strikingly high frequency. Preliminary observations tend to correlate this CREF cell killing with the accumulation of the early
viral proteins and/or viral DNA in the infected cells. This degree of cell damage was not observed in Ad5wt or H5sub304
infection of CREF cells. The observed E1a reiterations provide a model to gain insight into understanding the evolutionary
events of some, if not all, adenovirus types during many years of symbiotic, persistent relationship in human tonsils and
adenoids and possibly other lymphoid organs. q 1997 Academic Press
INTRODUCTION respiratory disease in Prague in 1978–1979 (8), and two
new genotypes of Ad7 alternately appeared during the
The first adenoviruses were isolated from latent infec-
1958–1980 epidemic outbreaks in Europe (47). These
tions of tonsils and adenoids (39) and from United States
observations provide evidence on the evolution of adeno-
Army recruits suffering from ‘‘Acute Respiratory Disease
viruses and suggest a possible origin of new pathogenic
of Recruits (ARD)’’ recognized during World War II (19).
adenovirus strains in the past and future. Nevertheless,
The history of human infections with adenoviruses can
none of these reports provide DNA sequence data, and
be traced back to at least as early as the 1940’s (13). It
the molecular basis of the described genetic changes
is not clear, however, as to how adenoviruses evolved
remain unknown.
during many years of relationship with human beings. It
Adenoviruses undergo spontaneous genetic changes
has been recently noticed that adenoviruses isolated
within infected cells. These changes may include dele-
from different regions of the world can be grouped into tions, insertions, translocations, substitutions (reviewed
different ‘‘genomic clusters’’ in addition to immunological in 49), and reiterations (23, 24) of the viral DNA se-
groups. Members in a ‘‘cluster’’ share similar changes in quences. Such mutations, like that of many exogenous
the migration pattern of one or more of their restriction DNA molecules, may result from intra- or intermolecular
DNA fragments as compared with the prototype virus to DNA recombination in the host cells through homologous
which these isolates are serologically related (26). For recombination (overlapping) and/or illegitimate recombi-
example, while the prototypes of Ad3, Ad7, and Ad11 (of nation (38, 49). The former requires extended homolo-
subgroup B), and Ad4 (of subgroup E) can no longer be gous sequences between two partner DNA molecules,
isolated (26), new genomic types of Ad2, Ad5, and Ad7 and the latter joins DNA ends with either very limited
have been isolated (1, 8, 46). It is noteworthy that the homology (within only 1–5 nucleotides) or no homology
new genotype, Ad5a, was responsible for an outbreak of at all (32, 33, 44). It has been noticed that mammalian
cells have a remarkable ability to join virtually any two
1 Present address: Institute for Molecular Virology, St. Louis Univer- DNA ends together, and a variety of mechanisms may
sity Health Sciences Center, 3681 Park Ave, St. Louis, MO 63110. be responsible for these recombination events (see re-2 To whom correspondence and reprint requests should be ad-
view, 38). However, knowledge about the cellular factorsdressed at National Institute of Allergy and Infectious Diseases, Na-
involved and the detail of the process are yet to be ex-tional Institutes of Health, Twinbrook II Facility, 12441 Parklawn Drive,
Rockville, MD 20852. plored. A study of the appearance of spontaneous viral
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mutants, particularly in adenovirus persistent infections exhibit evolutionary alterations. Hirt DNAs were prepared
(20, 45) and analyzed with restriction enzymes. The vi-in which viral DNA does not integrate, should lead to
a better understanding of the molecular basis of viral ruses that showed restriction map changes (i.e., changes
in the number and migration pattern of restriction frag-evolution.
To study the mechanism of adenovirus persistent in- ments) were plaque purified two more times on HeLa
monolayers, and reconfirmed by restriction analysis.fection of tonsils and adenoids, and to investigate the
intimate relationship of adenoviruses with human lym- When more accurate size measurements of the restric-
tion fragments were needed, the migration distance (inphocytes, an Ad5 persistent infection was established in
the Molt 4 lymphocyte cell line. The persistent infection mm) and the logarithm of the size (in m.u.) were plotted
onto a coordinate chart, using the wild-type fragmentswas initiated with a very low viral infectious dose (14).
This paper reports the isolation and characterization of as standards.
Ad5 reiteration mutants that spontaneously occurred and
Viral assaysaccumulated in the persistently infected Molt 4 lympho-
cyte system. The reiteration mutations, which were prob-
HeLa or A549 cell monolayers were used for plaque
ably created via a sequence-specific breaking and non-
assays (25, 48). Cell transformation was done in CREF
homologous recombination pattern, occurred in a six-
cell cultures (11). Indirect fluorescent focus assay (FFA)
base pair consensus DNA sequence within the second
was performed with KB cell monolayer cultures (34).
exon of the E1a region.
Cell survival assay
MATERIALS AND METHODS
Cell survival was determined as previously reported
Cell culture and virus (43). Briefly, CREF cells were infected at an m.o.i. of
10 PFU per cell. After 2 hr of adsorption, the infectedKB, HeLa, CREF (11), and A549 (12) cells were grown
cell monolayers were washed, trypsinized, and re-in Dulbecco’s Modified Eagle’s Medium (DME) supple-
seeded into 5 duplicate 60-mm plates with 100 cellsmented with 5% fetal calf serum. 293 cells (16) were
per plate. After 7 – 10 days of incubation at 377, cellpropagated in DME containing 10% fetal calf serum.
colonies were fixed, stained, and counted. Cell survivalAd5wt and H5sub304 (21) were replicated in KB cell cul-
was expressed as the average number of colonies pertures. H5sub304 bears a DNA substitution and viral ge-
100 infected cells. The cell survival of mock-infectednome deletion between 83.2 and 85.1 m.u. (1 m.u.  360
CREF cells was defined as 100%.base pairs, the full genome is 100 m.u.); it contains an
insertion of host DNA of 1.6 m.u. in size (a net deletion
Cloning and sequencing of DNA fragments
of 0.3 m.u.), around the XbaI site at 84.7 m.u., which
affects the genes that encode the 10.4- and 14.7-kDa Plasmid pPF400 (gift from P. Freimuth), which is a de-
proteins; and it is phenotypically wild type in viral replica- rivative of pBR322 with an XbaI linker inserted into AccI-
tion (21). The persistent infection system was initiated and SacI- sites, was used as the vector in DNA cloning.
by infection of Molt-4 cells with H5sub304 using 0.1 PFU/ DNA sequences were determined according to the
cell as previously reported (14). The last set of reiteration method of Maxam and Gilbert (29).
mutants was isolated 3 years after infection. Other E3
mutants used in the present investigation were Reciprocal recombination
H5sub309 (22). H2dl801 (9), and H5dl327 (41). H5sub309
To construct a hybrid virus composed of the left piecehas inherited the E3 mutation from its parent strain
of H5sub309 and right segment of H5wt genomesH5sub304, has a phenotype similar to wild-type Ad5, and
(termed sub309/wt), vDNA–protein complexes (DNA-PC)retains only one XbaI recognition site at 3.8 m.u. (22).
of two viral strains were prepared (37). Sub309 DNA-PCH2dl801 and H5dl327 have E3 deletions at 78.5–83.5
was digested with BamHI and EcoRI (for cutting the rightm.u. and 78.5–84.3 m.u., respectively (9, 41).
hand BamHI-B fragment) and H5wt DNA-PC digested
with SalI. Cotransfection of A549 cells was performedIsolation of reiteration mutants
using the calcium technique (17) with the mixed digested
DNA-PCs. The recovered infectious virus should only re-Cell suspensions were collected from the persistently
infected Molt-4 cell cultures, washed two times, and fro- sult from the overlapping between BamHI-A fragment (0–
59.5 m.u.) of sub309 and SalI-A fragment (45.9–100 m.u.).zen and thawed six times. After centrifugation, the super-
natants of the cell lysates were inoculated onto HeLa Plaques were picked, viruses were propagated, and Hirt
DNAs analyzed by XbaI digestion (the deletion of XbaIcell plates, overlaid with nutrition agar, and incubated at
377 as done in plaque assay (25, 48). Plaques were site at 3.7 m.u. makes sub309 distinguishable from
Ad5wt). The same procedure was used for constructingpicked and propagated only in KB cell cultures to obtain
those mutants that could persist in nature and possibly hybrid virus between NR3 and sub309/wt.
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Determination of synthesis of viral macromolecules in 181 were named NR or CR, since during Week 82 (Day
578), the infected Molt-4 cells were divided into two parts.infected cells
One sample was treated with normal rabbit serum (NR)
To observe the synthesis of viral early transcripts and and the other with rabbit antiserum (CR) for 5 weeks (14).
proteins, KB cells were infected, and incubated for 20 hr The rabbit antiserum added contained a concentration
in the presence of 50 mM hydroxyurea (2). Cytoplasmic of neutralizing antibodies in 10-fold excess of that re-
RNAs were first isolated, and poly(A)/ mRNAs were then quired to neutralize the quantity of infectious virus pres-
purified by oligo-dT cellulose chromatography (4), and ent in the culture.
used in identical amounts for Northern blot hybridization
employing the 32P-labeled pLB215 (containing Ad5hr1 0– Restriction enzyme analyses of the mutants
4.5 m.u. DNA fragment, (3)). The fluorescent focus assay A set of analyses with different restriction enzymes
(FFA) was employed to determine the expression of early indicated that all of the mutants isolated, except NR3,
viral proteins in CREF cells using anti-72 kDa protein had DNA sequences inserted within the E1a region, and
(E2a DNA-binding protein) rabbit antiserum prepared in these appeared to be reiterated sequences. No other
our laboratory. To measure vDNA replication in CREF mutations were apparent.
cells, 3H-TdR in vivo incorporation was employed (4). The As shown in Figs. 1A and 1B, mutants CR4, CR5, NR1,
radio-labeled vDNAs were isolated and hybridized to NC- NR2, NR4, NR5, HE24, and HE42 retained the size of the
paper with bound Ad5 vDNA. The counts of radioactivity XbaI-E fragment (0–3.7 m.u.) unchanged. Among these
were compared between the tested viruses. To deter- mutants, each mutant’s genome had gained an extra XbaI
mine the synthesis of viral late transcripts, RNAs were site to the right of 3.7 m.u.: HE42 gained one novel band
isolated at 48 hr p.i. from infected CREF cells from either of 2.0 m.u. in size, and the others gained a 2.3 m.u. band.
nuclei or cytoplasm (4), and hybridized with 32P-labeled Mutant HE23, however, with its XbaI-E fragment, which
probe plasmid pLB105, consisting of Ad5 28.8–59.5 m.u. corresponds to wt 0–3.7 m.u., migrated slower and had
DNA fragments that contain the penton- and hexon- cod- gained an insert of about 2.1 m.u. in size to the left of
ing regions (gift from L. E. Babiss), by dot blot as de- the XbaI site at 3.7 m.u. (Fig. 1A). The ClaI analysis (Fig.
scribed above. Late protein synthesis was detected by 1B) showed no change in size of the ClaI-B fragment (0–
FFA using anti-virion rabbit antiserum prepared in our 2.6 m.u.) in all mutants tested, which indicates that all
laboratory. FFA was also used to quantitate viral replica- of the inserted DNA sequences in these mutants were
tion yield. located to the right of 2.6 m.u. (ClaI site).
Further enzymatic analyses using HpaI and SacI (Fig.
RESULTS 1C) revealed that the HpaI-E (0–4.3 m.u.) and SacI-I (0–
4.8 m.u.) fragments of CR4, CR5, NR2, NR4, HE23, HE24,Isolation of the mutants
and HE42 (NR1 and NR5 were not analyzed) migrated
slower than that of H5sub304, their parent strain, indicat-A persistent infection of the Molt-4 lymphocyte cell
line was readily established with a low multiplicity of ing that these mutants had probably gained DNA se-
quences to the left of 4.3 m.u. Whereas the sizes of theH5sub304 but not with Ad5wt, as previously reported
(14). Infected Molt-4 cells were sampled at increasing insertions measured in NR2, CR5, and HE24 by HpaI and
SacI analyses (Fig. 1C) were the same (2.3 m.u.) as thattimes after infection, and a number of viral mutants were
isolated according to the protocol described under Mate- measured by XbaI analysis (Fig. 1A), HE23 showed an
insertion of 2.1 m.u. in size (Fig. 1C), which was slightlyrials and Methods. The mutants were selected and prop-
agated in KB cells to obtain only mutants that would smaller than that revealed by Xba analysis (2.3 m.u., Fig.
1A). The insertions of mutants CR4 and NR4 were 4.5–replicate and persist in normal cells and, therefore, mimic
the persistence and evolution of new adenoviruses in 5.0 m.u. in size, and that of HE42 was 4.1–4.3 m.u. in
size (Fig. 1C), which almost doubled that measured bynature. It was found that in infected cell samples taken
at Week 57, 49 of 63 plaque isolates (77.8%) were like XbaI analysis (2.3 m.u. for CR4 and NR4, 2.0 m.u. for
HE42, Fig. 1A).H5sub304, as determined by XbaI analysis, but the re-
maining 14 plaque isolates (22.2%) were mutants with These data suggested that: (1) HE23 has an insertion
sequence between 2.6 m.u. (ClaI) and 3.7 m.u. (XbaI);one of the restriction fragments of increased size. In the
samples collected at 181 weeks, however, 11 of 12 (2) the other mutants mentioned above have insertions
located between the 3.7 m.u. (XbaI) and 4.3 m.u. (HpaI);plaque isolates (83.3%) were mutants with inserted DNA
sequences, and the twelfth isolate, NR3, probably has and (3) these inserted sequences most likely contain
one or two reiterated repeats. Analysis with additionalanother mutation in the left hand region of the viral ge-
nome (see text below). Four representative mutants were restriction enzymes (data not shown) indicated that the
sizes and locations of the observed reiteration mutationslater shown to have part of their E1a DNA sequences
reiterated (see text below). The mutants isolated at Week are predictable, as presented in Fig. 2. To explain this
prediction, two examples are presented:57 were termed HE, and the mutants isolated at Week
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FIG. 1. Enzymatic analyses of Ad5 reiteration mutants. Hirt DNAs were isolated from KB cells infected (5 m.o.i.) with Ad5 reiteration mutants and
the parent strain, H5sub304, and analyzed with restriction enzymes XbaI (A), ClaI (B), and HpaI and SacI (C). Analyses of HE23 with ClaI and SmaI
are presented in D.
Example 1. The inserts of CR4 and NR4 were analyzed This distance was proved by ClaI/SmaI digestion (data
not shown).with HpaI and SacI and shown to be 4.5–5.0 m.u. in size
(Fig. 1C), which was two times larger than that measured It should be noted that all NR mutants, including NR3,
had an extra deletion at the right hand end of the genomewith XbaI and ClaI (2.3 m.u., Figs. 1A and 1B), or with
SmaI (data not shown). A reasonable explanation for the as compared with sub304, CR mutants, and HE mutants.
As shown in Fig. 1A, a XbaI–A/D/C fusion fragment wasdiscrepancy is that (1) these two mutants have an insert
that contains two tandem repeats, (2) each repeat has produced with each of the NR mutants that replaced the
XbaI-D/C and XbaI-A fragments produced by sub304 andone XbaI, one SmaI, and one ClaI site, (3) each pair of
sites for one of these enzymes (XbaI–XbaI, SmaI–SmaI, other CR mutants or HE mutants. Similar results were
seen with SacI analysis (Fig. 1C). The mapping of thisand ClaI–ClaI) is separated by a distance of 2.3 m.u., or
(4) the XbaI, SmaI, and ClaI sites in each repeat are extra deletion and its potential biological effects will be
discussed below.equally separated from that in the wt genome, i.e., by 0.9
m.u. and 0.2 m.u., respectively. It should also be noted that all of the breakpoints in
these mutants resided around the XbaI site at 3.7 m.u., and,Example 2. Mutant HE23 DNA digested with XbaI,
HpaI, and SacI (Figs. 1A and 1C) showed an insert of therefore, were within the second exon of the Ad5 E1a
region (see top of Fig. 4). According to the similarity of the2.1–2.3 m.u. in size, and the ClaI-B (0–2.6 m.u.) and
SmaI-K (0–2.8 m.u.) fragments were unchanged (Fig. 1D). size and localization of the inserted sequences (Fig. 2), four
mutants, NR2, CR4, HE42, and HE23, were selected asHowever, the ClaI and SmaI digestions resulted in an
extra 1.5 m.u. fragment (Fig. 1D). These results indicate representative mutant strains for further investigation.
that (1) HE23 gained an insert of 2.1–2.3 m.u. in size
Cloning and DNA sequencing of the jointsbetween sites at 2.8 m.u. (SmaI) and 3.7 m.u. (XbaI), and
(2) there were ClaI and SmaI sites in the insert separated To determine the precise locations of these insertions,
and to determine whether sequence specificity existedby a distance equal to that on the wt genome (0.2 m.u.).
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Comparison of the DNA sequences of the upstream
inserted sequences and the breakpoints did not reveal
any sequence homology (Fig. 3). These data suggest that
sequence-specific recognition/breaking in the second
exon, nonspecific breakage in the sequences around the
first exon, and nonhomologous end–end joining were
responsible for the observed reiteration mutations in the
Ad5 E1a region.
The data of DNA sequences at the joints also revealed
some information about the alterations of the coding se-
quences at the joints. Three possible patterns are sug-
gested (Fig. 3). In the case of HE42, the second exon
broke at nt 1442 and the incoming sequences were
headed by nt 710. This crossing-over would not have
changed the normal reading frame, but resulted in an in-
frame fusion protein. In the case of NR2 and CR4, the
second exon broke at nt 1368. Since the incoming se-
quences began at nt 532, which was located toward the
5*-end of the first exon, nine amino acids would thus be
coded by the otherwise noncoding region (nt 532–559)
and be added to the N*-terminus of the first exon. Further-FIG. 2. Sizes and locations of reiteration mutations in the E1a region
more, this insertion brought a frame shift to the followingof Ad5 genome. The inserted DNA, identified by restriction enzyme
analyses, were cloned, and the DNA of the joints identified were se- first exon, which resulted in 29 new codons followed by
quenced. C, ClaI; S, SmaI; X, XbaI; and H, HpaI. Bold lines indicate the two tandem stop codons (TGA-TAA, beginning at nt 646)
joints that were further cloned and sequenced. The left-most recogni- created by this frame shift. In the case of HE23, the
tion sites of the restriction enzymes used are noted on the top.
reading frame was not changed by the crossing-over,
but the codon ATT (nt 791–793, coding for isoleucine)
in the recombination events, cloning (data not shown) was changed to CGT (nt 1333, 1334/or 792, and 793, for
and DNA sequencing of the ‘‘joints’’ were done. The joints
selected were (Fig. 2): the 1.2 m.u.-sized XbaI/ClaI joint
of NR2 and CR4, the 0.9 m.u.-sized XbaI/ClaI joint of
HE42, and the 1.5 m.u.-sized SmaI/ClaI joint of HE23.
According to the DNA sequencing data of these joints
(Fig. 3), and in accord with the sizes and locations of
the inserts presented in Fig. 2, the predicted genomic
structures of these mutants are schematically presented
in Fig. 4.
All four joints bear a six-base-pair consensus se-
quence, G(or C)CTGTG, and the DNA sequences in-
serted into the breakpoints of these mutants were all
sequences to the left of or within the first exon of E1a
(Figs. 3 and 4). The consensus sequence used by these
four mutants were found in the Wt E1a second exon
(Figs. 3 and 4) at nt 1333 –1338 (for HE23), nt 1367–1372
(for NR2 and CR4), and nt 1419–1424 (for HE42). The
breakpoints for three of the four mutants were after nt
1368 (for NR2 and CR4), or after nt 1422 (for HE42). In
case of HE23, however, the breakpoint could not be pre-
cisely determined since there was a point mutation at
this joint. The breakpoint might be after nt 1333 or 1334.
FIG. 3. Sequences at the joints of representative reiteration mutants.In the former case, the first residue at the 5* end of the
Crossing-over locations are depicted by the zigzag lines; two possibleinsert (i.e., nt 792) must have been changed from T to G;
patterns are shown at the joint of the HE23 genome. Asterisk markersin the later case, however, nt 1334 might have been
indicate homologous base-pairs. The short vertical line in the HE23
changed from C to G before ligating to the oncoming nt joint indicates location of a point mutation, the T/A at nt792 and the
793 (T) (Fig. 3). Both possibilities are depicted in Fig. 3, C/G at nt1334 shown are replaced by a G/C pair. At certain positions
triplet codons are indicated by short lines.and only the first possibility is shown in Fig. 4.
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sequences of the three mutants shown in Fig. 4. Further-
more, the Northern blots showed that the amounts (as
indicated by intensity of the corresponding bands) of the
largest size mRNA products (bands at top, lanes 2–5,
Fig. 5) of each mutant were obviously greater than those
of the smaller size mRNAs. For example, CR4 or HE42
(lanes 3 and 4) yielded three mRNA bands, the top band
was more intense than the other two bands. Similar find-
ings were obtained with NR2 and HE23 (lanes 2 and 5).
It is concluded, therefore, that: (1) the DNAs of the E1a
region in these representative mutants are reiterated as
depicted in Fig. 4; (2) the reiterated splicing joints may
all be used in mRNA splicing events, producing several
levels of mRNA products; and (3) the closest donor and
recipient joints are mostly used in splicing, producing
the largest mRNA products with greater amounts than
smaller products.
Biological properties of the reiteration mutants
Since the E1a genes code for several dual functions,
e.g., transactivation and transformation (5, 15), and the
reiteration mutations described above encompassed the
E1a region, it was important to determine the impact of
these mutations on E1a functions. Preliminary character-
ization of the four representative mutants were therefore
performed.
1. Viral replication. Single-step viral replication experi-FIG. 4. Schematic presentation of the DNA reiterated sequences of
Ad5 reiteration mutants. The patterns of DNA reiteration within the 0– ments at either 377 (48 hr) or 327 (72 hr) indicated that
5 m.u. region of the Ad5 mutants are indicated. The 6-bp consensus the four representative mutants replicated like wild-type
sequence G(/C)CTGTG at the joints is noted. The DNA structure of the Ad5 in HeLa, KB, and A549 cells (i.e., had identical latent
Ad5 E1a region is shown at the top; the boxes numbered 1–3 are the
periods and viral yields). Moreover, like Ad5Wt andfunctional domains of this region. Nucleotide numbers are indicated
sub304 these mutants did not replicate in CREF cellsat the joints and at the enzyme recognition sites.
(data not shown).
Plaque assays were done on A549 cells. In this assay
arginine) by either of the possible recombination patterns (data not shown), all four mutants tested, and NR3 as
discussed above and shown in Fig. 3.
It should be pointed out that, although these mutants
might make different fusion proteins, they could also
make wild-type E1a proteins. This conclusion results
from the Northern blot analysis (see below) which dem-
onstrated that wild type E1a mRNAs, along with the reit-
erated mRNAs, were detected in every reiteration mutant
analyzed.
The mutants E1a messenger RNA synthesis
To determine whether these mutants synthesize nor-
mal or unusual E1a mRNAs in permissive cells, Northern
blot analyses were done. The results (Fig. 5) demonstrate
that each mutant tested yielded two or three mRNA
bands, and the number of mRNA bands from each mutant
FIG. 5. E1a mRNAs synthesized by the Ad5 reiteration mutants: Earlywas the same as that of the reiteration events predicted
mRNAs were isolated from KB cells infected with the Ad5 reiterationin Fig. 4, while sub304 yielded only one mRNA band
mutants and the parent strain, H5sub304 (described under Materials
since the 12S and 13S mRNAs did not separate under and Methods). Northern blot hybridization was used to identify Ad5
the conditions employed (lane 1). These data strongly E1a mRNAs using 32P-labeled plasmid pLB215, which contains the Ad5
E1a DNA.support the predicted reiteration pattern of the E1a DNA
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TABLE 1 mutants produced severe cell damage and death of
CREF cells (Table 1), it was not possible to calculate theCell Survival Assay of Ad5 Reiteration Mutants in CREF Cellsa
transformation efficiency accurately nor to compare the
Adjusted cell efficiency between different viral strains, since a small
Virus Colonies/100 cells survival (%) difference in the cell survival measurement would result
in a significant difference in the adjusted transformation
Sub304 46.33 62.33
efficiency. Of the infected CREF cells that survived infec-NR2 1.50 2.02
tion, however, the morphological changes of cells wereCR4 3.17 4.30
HE42 7.33 9.90 those of transformed CREF cells. Therefore, these reiter-
HE23 4.67 6.30 ation mutants, like Ad5wt and sub304, did transform
NR3 4.03 5.43 CREF cells, and produced completely transformed cell
None 74.33 100.00
foci (data not shown), which consisted of cells with both
epithelial and fibroblast morphology. In contrast, othera CREF cells were infected at a m.o.i. of 10 PFU per cell. AFter 2 hr
of adsorption, 100 infected cells were reseeded into each of 5 duplicate previously reported Ad5 E1a mutants only form incom-
60-mm plates; cell colonies were counted after 7 to 10 days of incuba- pletely transformed foci, which only consist of cells with
tion. Cell survival was expressed as the average number of colonies fibroblast morphology (3, 43).
per 100 infected cells. The cell survival of mock-infected CREF cells
4. Synthesis of viral macromolecules. To correlate thewas defined as 100%.
observed unusual capability of the mutants to kill CREF
cells with the special step(s) or product(s) of the abortive
viral replication cycle, the synthesis of viral macromoleculeswell, produced large plaques (5–7 mm in diameter), as
did their parent sub304. CR4 even produced larger in infected CREF cells were determined. As summarized in
Table 2, these mutants synthesized early proteins in CREFplaques (7–9 mm in diameter). This result was not unex-
pected since sub304 was previously observed to pro- cells, as determined by FFA using anti-72Kd serum; they
replicated their viral DNAs as determined by 3H-TdR incor-duce large plaques in HeLa cells (27). However, H2dl801
(bearing an E3 deletion of 78.5–83.5 m.u. (9)) and poration and dot hybridization; synthesized late transcripts
in nuclei but they were not transported into the cytoplasmH5dl327, which has an E3 deletion of 78.5–84.3 m.u. (41),
produced fuzzy plaques of only 1–3 mm in diameter in (Table 2); and they did not produce detectable late proteins
as determined by FFA with anti-virion serum. Moreover, thethe same plaque assay. It thus became difficult to judge
as to which gene(s) was responsible for the size of mutants did not produce infectious virus (data not shown).
H5sub304, as a control, replicated viral DNA at a relativelyplaques, as previously discussed (30).
During the process of isolation, all of the reiteration low level in CREF cells, and the amount of 72K protein
produced was probably too little to be detected under themutants studied had been plaque-to-plaque purified
three times, and at each passage the Hirt DNAs were test conditions (Table 2). These data indicate that the viral
replication cycles of these reiteration mutants are blockedanalyzed with restriction enzymes. The mutants all re-
tained the altered restriction pattern. These data indicate at late stages in CREF cells. These findings also suggest
that the accumulation of early proteins and/or viral DNA isthat the mutants described are genetically stable, and
that there was not any packaging problems owing to the related to the observed damage of the mutant-infected
CREF cells.increased size of their genomes.
2. Effect of reiteration mutants on CREF cells. CREF Correlation between E1A mutations and phenotypes.
The data obtained indicate that the phenotypes of thecells are totally nonpermissive for production of infec-
tious Ad5 virus, and Ad5 Wt transforms these cells at a reiteration mutants like CR4, HE42, and HE23, are linked
to the E1a reiteration mutations following the breakpointmarkedly increased frequency (11). However, when
CREF cells were infected with the reiteration mutants, all in the E1a second exon, since, compared with sub304,
the only detected mutations of these mutants were thefour mutants killed the CREF cells at a very high fre-
quency. It was repeatedly observed that when CREF cells sequence reiterations in the E1a region of the genome.
The ‘‘NR’’ mutants, however, appear to be more complex:were infected with any one of the mutants at a m.o.i. of
10 PFU/cell, all four mutants killed 90–98% of the cells, in addition to the sub304’s deletion around 84.7 m.u. (a
net deletion of 0.3 m.u. in size), all of the NR mutantswhile their parent, H5sub304, and Ad5wt killed less than
40% of the infected CREF cells (the results of one typical have an additional deletion within the E3 region. A set
of restriction enzyme analyses were performed to mapexperiment is shown in Table 1). The mutant NR3 also
killed the CREF cells (Table 1) and will be discussed this extra deletion using XbaI, SacI (Figs. 1A and 1C),
and other enzymes (not shown). The extra deletion wasbelow.
3. Cell transformation. Transformation efficiency is mapped within the SmaI-B fragment (76.6–91.9 m.u.),
XhoI-D fragment (70.0–82.7 m.u.), SacI D fragment (76.2–routinely expressed as the number of transformed foci
per 105 infected cells, and this efficiency is subject to 84.0 m.u.), and BglII F fragment (77.9–84.2 m.u.). These
analyses indicated that the deletion was 0.7 m.u. in size,adjustment by cell survival (43). However, because these
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TABLE 2
Macromolecular Synthesis and Viral Replication of Ad5 Reiteration Mutants in CREF Cellsa
Reiteration mutants
Sub304 NR2 CR4 HE42 HE23 NR3
72K protein 0 / / / / ND
vDNA replication 5.25 44.33 23.86 14.34 18.40 35.43
Late transcripts
Nuclei 120.0 2820.5 330.4 1107.5 872.5 525.0
Cytoplasm 0 0 0 0 0 ND
Late protein 0 0 0 0 0 0
Viral replication 0 0 0 0 0 0
a The syntheses of 72K- and late proteins were assayed by indirect fluorescent focus assay (FFA). Viral DNA replication was measured by the
incorporation of 3H-TdR; the numbers indicate the counts per minute (cpm) of radioactivity hybridized to viral DNA recorded in one representative
experiment. Late RNA transcripts were detected by dot-hybridization with the 32P-labeled plasmid pLB105 (Ad5 hexon). Viral replication was tested
by titrating the yields harvested at different time points, by FFA on 293 cells. ND, not done.
was probably located around the XbaI site at 78.5 m.u., viruses was measured. Initially, a phenotypically wild-
type virus hybrid, termed 9-3, was created by overlappingand was between 77.9 and 82.7 m.u..
One isolate, NR3, which shared this extra E3 deletion the BamHI-A fragments (0–59.9 m.u.) of sub309 and the
SalI-A fragment (45.9–100 m.u.) of Ad5Wt (described un-with other NR mutants (Figs. 1A and 1C), showed a phe-
notype similar to the reiteration mutants (Tables 1 and der Materials and Methods). The reciprocal recombina-
tions between NR3 and 9-3 were then done using the2). NR3, however, did not have a detectable left hand
reiteration mutation (Figs. 1A–1C). As shown in Tables same procedure. The resulting hybrid viruses were
termed NR3/9-3 or 9-3/NR3, indicating the locations of1 and 2, NR3 replicated its DNA in CREF cells, killed
CREF cells at a high frequency, and the late stage of the NR3-original DNA fragment (whether it was located
at the left or right hand portion of the hybrid genome).viral replication in CREF cells was also blocked. Thus,
NR3 had the same phenotype as the reiteration mutants The purpose in making sub309/Ad5wt hybrid (9-3) first
was that the XbaI site at 29 m.u. was missing in sub309,without having a detectable E1a reiteration. There could
be two possibilities for this discrepancy: (1) NR3 might which made the left hand region distinguishable from
that of NR3. There was no difficulty in distinguishing thehave minor mutation(s) in the E1a region that was not
detectable by restriction enzyme analyses; and (2) if there right hand region of NR3 genome from that of Ad5wt,
since two XbaI sites in the right hand portion were miss-was not a mutation in the E1a region of the NR3 genome,
the second deletion around 78.5 m.u. within the E3 region ing in NR3. The CREF cell-killing phenotype of NR/9-3
and 9-3/NR were compared with NR3, sub304, Ad5wt, 9-might be responsible for the cell killing phenotype. How-
ever, the latter hypothesis did not seem as reasonable 3, and two other E3 mutants (H2dl801 and H5dl327). The
results (Table 3) indicate that NR3/9-3 killed CREF cellsas the former one, since if it had been the case, there
would be different genetic explanations for the observed to an extent (93.4%) close to that of NR3 (95.2%), but 9-
3/NR3 showed a reduced killing ability (67.3%), andcell killing. Thus, the E1a reiteration and the extra E3
deletion could have contributed to the cell killing via dif- sub304 and 9-3 only killed 18.2 and 28.2%, respectively.
These data suggested that the left hand of NR3 genomeferent mechanisms (i.e., the CR and HE mutants in con-
trast with the NR mutants with or without E1a reiteration was primarily responsible for the observed cell killing
phenotype, i.e., there probably is a minor mutation in themutation). To investigate this puzzle, NR3 was further
characterized. E1a region that unfortunately was not detected or was
beyond the DNA region sequenced (e.g., the region be-The E1a region of NR3 was sequenced from 3.7 m.u.
(XbaI site) and 2.8 m.u. (SmaI site) in both directions (data tween nt560 and nt900). The additional E3 deletion in
NR3, however, probably also contributes to the high le-not shown). No mutations were found between nt 900
and nt 1520, which did not cover the whole E1a coding thal effect of NR3 in CREF cells.
region (nt 559–nt 1545), but included all of the se-
quenced breakpoints of the four reiteration mutants. DISCUSSION
To determine whether the left or right 50 to 60% of the
genome of NR3 was related to the cell killing phenotype, DNA sequence reiterations have been observed in
DNA viruses such as SV40 (7), vaccinia virus (31), andreciprocal recombination was done to link the left or right
hand of NR3 genome to the opposite region of the wild- polyoma virus (40) accompanying the passage of wild-
type viruses at high multiplicities. This procedure wastype genome, and the cell killing ability of these hybrid
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TABLE 3 three types of processes involved in the inter- or intramo-
lecular illegitimate recombination that resulted in the ob-Cell Survival of CREF Cells after Infection with Adenovirusa
served E1a reiteration mutations: a sequence-specific
Virusb Experiment I Experiment II DNA recognition/breakage in the E1a second exon, a
random DNA double-strand shearing in the E1a first
H5sub304 81.8 62.3 exon, and a nonhomologous end–end joining. It is note-
9-3 71.83 NDc
worthy that the same six base-pair consensus sequenceNR3 4.8 8.5
also appeared at the crossover region of a reiterationNR3/9-3 6.6 ND
9-3/NR3 32.7 ND mutation in the ITR of Ad3, although it was not reported
H2d1801 ND 62.3 as a consensus sequence (23). In one of the reiteration
H5d1327 ND 52.3
mutants described in this report, HE23, a point mutationNone 100 100
was observed in the crossover sequence. This is consis-
a Cell survival was expressed as number of surviving cells per 100 tent with previous findings that subtle illigitmate recombi-
infected CREF cells (see Materials and Methods and legend of Table 1). nation mutations occur at the termini (23). The mutants
b Sub304 has a deletion between 83.2 and 85.1 m.u.; NR3 has a bearing E1a reiteration–insertion mutations showed al-
deletion of 0.7 m.u. in size, around 78.5 m.u., at 77.9–82.8 m.u., in
tered biological properties such as increased plaqueaddition to the deletion inherited from sub304; H2d1801 has a deletion
sizes in permissive cells, which is consistent with theirat 78.5–83.5 m.u.; and H5d1327 has a deletion at 78.5–84.3 m.u. 9-3,
hybrid of sub309 (left) and Ad5wt (right); NR3/9-3, hybrid of NR3 (L) and ability to cause severe cell damage to otherwise nonper-
9-3 (R); 9-3/NR3, hybrid of 9-3 (L) and NR3 (R); as described under missive CREF cells, which show a high adenovirus-trans-
Materials and Methods. formation frequency (11).c ND, not done.
It is not clear as to what cellular factors are involved
in the illegitimate recombination events observed in eu-
also used to isolate adenovirus reiteration mutants, from karyotic cells, especially in mammalian cells. However,
Ad16 (18) and Ad3 (24). Compared with these previous some DNA-binding enzymes, like topoisomerase I (topo
investigations, the isolation of spontaneous reiteration I), or topoisomerase II (topo II), are regarded as possible
mutants of Ad5 reported in this paper resulted from a candidates. These enzymes introduce transient protein-
substantially different protocol. (1) The reiteration mu- bridged DNA breaks on one (type I) or both DNA strands
tants were not isolated as a result of passage of virus (type II) to solve transiently the conformational and topo-
at a high multiplicity, which usually lasted only a few
logic problems of DNA during replication and transcrip-
passages, but rather as a result of a persistent infection
tion in mammalian cells (10, 28, 38). There are some
in lymphocytes for 3 years, which was initiated with a
degenerate consensus sequences reported that topo I
very low m.o.i. of 0.1 PFU/cell (14). This protocol was
and topo II recognize, including the in vitro consensusdeveloped to mimic the natural persistent adenovirus
sequences for topo I in SV40 DNA (35); the hexadecamerinfection of tonsils and adenoids in humans (39). (2) Ap-
high affinity sequence on tetrahymena rDNA not foundparently, the mutants replaced H5sub304 virus during
in SV40 DNA, but also found in mammalian cells (6, 35);the 3-year period of infection. This extent of mutant virus
and the topo II recognized sequence (42). While the six-accumulation was not observed in the other systems
base-pair consensus sequence reported in the presentdescribed. (3) The reiterated region encompassed the
paper, G(or C)TGTG, does not match the topo I consen-E1a region. (4) There was a six-base-pair consensus
sus sequences, it shows similarity to that for topo IIDNA sequence, G(or C)CTGTG, found at the breakpoint
(42), especially in mutants NR2 and CR4 where thein the Ad5 genome. (5) Finally, these reiteration mutants
breakpoints were between GC and TGTG. Whether toposhowed a striking ability to kill the otherwise nonpermis-
II or other enzymes are involved in the multiple pathwayssive CREF cells. These characteristics make this persis-
leading to the reiteration mutations observed requirestent infection system a useful research model to study
further investigation.viral evolution as well as the interaction of adenoviruses
The Northern blot analyses indicated that the closestwith its human host, including the mechanisms of viral
donor and recipient sites were probably the preferredDNA repair/recombination. It is noteworthy that in this
splicing sites. These results agree with the Reed andlaboratory model, like in humans, the adenovirus infec-
Maniatis investigation (36) which showed that the prox-tion persists even in the presence of Ad5-specific neu-
imity of the 5* and 3* splice sites is an important determi-tralizing antibodies (14).
nant in the selection of splice-sites.The data reported demonstrate that the E1a reitera-
The reiteration events reported in this paper may pres-tions occurred at a six-base-pair consensus sequence,
ent a possible mechanism for the evolution of adenovi-G(or C)TGTG, in the E1a second exon, and the reiterated
ruses, and a potential origin of novel pathogenic adenovi-sequences came from the region to the left or within the
rus strains, during long periods of persistent, symbioticleft end of the first exon, which did not share homology
with the breakpoints in the second exon. There may be relationships in human beings.
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